Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prins

Showing results (691-700 of 722) with videos related to

Pageof 73
Sort By:
British Journal of Cancer|September 5, 2013
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancerN Snoeren, B L Emmink, M J G Koerkamp, et al.
Science Signaling|December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapyDeliang Guo, Robert M Prins, Julie Dang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 29, 2024
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster doseGeert V T Roozen, Manon L M Prins, Corine Prins, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
The Netherlands Journal of Medicine|January 8, 2014
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the NetherlandsS M Huijts, C H van Werkhoven, W G Boersma, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
BMJ Open|April 21, 2023
Safe shortening of antibiotic treatment duration for complicated <i>Staphylococcus aureus</i> bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatmentDtp Buis, C H van Werkhoven, M A van Agtmael, et al.
JAMA|July 13, 2016
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
Journal of Surgical Oncology|July 9, 2025
Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of DiseaseStuart A Fine, Sin Yee Lim, Nicholas M Siena, et al.
NPJ Vaccines|January 3, 2024
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trialManon L M Prins, Geert V T Roozen, Cilia R Pothast, et al.
Pageof 73

Showing results (691-700 of 722) with videos related to

Sort By:
Pageof 73
British Journal of Cancer|September 5, 2013
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancerN Snoeren, B L Emmink, M J G Koerkamp, et al.
Science Signaling|December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapyDeliang Guo, Robert M Prins, Julie Dang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 29, 2024
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster doseGeert V T Roozen, Manon L M Prins, Corine Prins, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
The Netherlands Journal of Medicine|January 8, 2014
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the NetherlandsS M Huijts, C H van Werkhoven, W G Boersma, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
BMJ Open|April 21, 2023
Safe shortening of antibiotic treatment duration for complicated <i>Staphylococcus aureus</i> bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatmentDtp Buis, C H van Werkhoven, M A van Agtmael, et al.
JAMA|July 13, 2016
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
Journal of Surgical Oncology|July 9, 2025
Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of DiseaseStuart A Fine, Sin Yee Lim, Nicholas M Siena, et al.
NPJ Vaccines|January 3, 2024
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trialManon L M Prins, Geert V T Roozen, Cilia R Pothast, et al.
Pageof 73